[Correlation of expression of epidermal growth factor receptor-2 expression and tumor marker p53 in primary breast cancer].
To observe the correlation between expression of epidermal growth factor receptor (HER)-2 and tumor marker p53 in breast cancer. specimens of primary breast cancer were collected from 2996l patients, all female, aged 50 (15 - 92). All of the cases were confirmed by pathohistological method. Immunohistochemistry was used to detect the expression of estrogen receptor (ER), progesterone receptor (PR), Her-2, and p53. 680 cases (22.7%) showed HER-2 overexpression, among which 378 cases (12.6%) were HER-2 weak positive (++) and 302 cases (10.1%) were HER-2 strong positive (+++). 935 cases were p53 positive and 2061 cases were p53 negative. The HER-2 overexpression rate was 32.3% in the p53-positive patients and 18.4% in the p53-negative patients. Expression of HER-2 was positively correlated with expression of p53 (P < 0.01). Expression of p53 is the independent index of HER-2 expression, and there is a positive correlation between expression of HER-2 and expression of p53.